LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
NASDAQ:LMAT - Nasdaq - US5255582018 - Common Stock - Currency: USD
Overall LMAT gets a fundamental rating of 7 out of 10. We evaluated LMAT against 187 industry peers in the Health Care Equipment & Supplies industry. LMAT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LMAT has a decent growth rate and is not valued too expensively. These ratings would make LMAT suitable for quality investing!
1. Profitability
1.1 Basic Checks
LMAT had positive earnings in the past year.
LMAT had a positive operating cash flow in the past year.
In the past 5 years LMAT has always been profitable.
LMAT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
LMAT has a Return On Assets of 8.12%. This is amongst the best in the industry. LMAT outperforms 91.44% of its industry peers.
LMAT has a Return On Equity of 12.99%. This is amongst the best in the industry. LMAT outperforms 89.84% of its industry peers.
LMAT's Return On Invested Capital of 7.67% is amongst the best of the industry. LMAT outperforms 86.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LMAT is in line with the industry average of 7.91%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.12% | ||
| ROE | 12.99% | ||
| ROIC | 7.67% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
LMAT's Profit Margin of 19.96% is amongst the best of the industry. LMAT outperforms 94.65% of its industry peers.
In the last couple of years the Profit Margin of LMAT has grown nicely.
Looking at the Operating Margin, with a value of 23.43%, LMAT belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
LMAT's Operating Margin has improved in the last couple of years.
LMAT has a Gross Margin of 68.80%. This is in the better half of the industry: LMAT outperforms 77.54% of its industry peers.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 19.96% | ||
| GM | 68.8% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
LMAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, LMAT has more shares outstanding
The number of shares outstanding for LMAT has been increased compared to 5 years ago.
The debt/assets ratio for LMAT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 7.18 indicates that LMAT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.18, LMAT belongs to the best of the industry, outperforming 86.10% of the companies in the same industry.
LMAT has a debt to FCF ratio of 4.09. This is a neutral value as LMAT would need 4.09 years to pay back of all of its debts.
LMAT's Debt to FCF ratio of 4.09 is amongst the best of the industry. LMAT outperforms 85.56% of its industry peers.
LMAT has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
LMAT has a Debt to Equity ratio of 0.48. This is comparable to the rest of the industry: LMAT outperforms 42.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 4.09 | ||
| Altman-Z | 7.18 |
ROIC/WACC0.87
WACC8.81%
2.3 Liquidity
LMAT has a Current Ratio of 16.49. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 16.49, LMAT belongs to the top of the industry, outperforming 97.86% of the companies in the same industry.
LMAT has a Quick Ratio of 13.83. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 13.83, LMAT belongs to the best of the industry, outperforming 95.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.49 | ||
| Quick Ratio | 13.83 |
3. Growth
3.1 Past
LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.13%, which is quite impressive.
Measured over the past years, LMAT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.13% on average per year.
The Revenue has grown by 13.19% in the past year. This is quite good.
Measured over the past years, LMAT shows a quite strong growth in Revenue. The Revenue has been growing by 13.41% on average per year.
EPS 1Y (TTM)31.13%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%9.09%
Revenue 1Y (TTM)13.19%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.95%
3.2 Future
Based on estimates for the next years, LMAT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.65% on average per year.
The Revenue is expected to grow by 9.07% on average over the next years. This is quite good.
EPS Next Y13.23%
EPS Next 2Y11.97%
EPS Next 3Y12.28%
EPS Next 5Y8.65%
Revenue Next Year11.52%
Revenue Next 2Y10.16%
Revenue Next 3Y10.14%
Revenue Next 5Y9.07%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 40.87, the valuation of LMAT can be described as expensive.
LMAT's Price/Earnings ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 70.59% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.35. LMAT is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 33.27, LMAT can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 37.54. LMAT is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.87 | ||
| Fwd PE | 33.27 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than the industry average as 73.26% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.46 | ||
| EV/EBITDA | 22.48 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of LMAT may justify a higher PE ratio.
A more expensive valuation may be justified as LMAT's earnings are expected to grow with 12.28% in the coming years.
PEG (NY)3.09
PEG (5Y)2.39
EPS Next 2Y11.97%
EPS Next 3Y12.28%
5. Dividend
5.1 Amount
LMAT has a yearly dividend return of 0.97%, which is pretty low.
Compared to an average industry Dividend Yield of 1.91, LMAT pays a better dividend. On top of this LMAT pays more dividend than 92.51% of the companies listed in the same industry.
With a Dividend Yield of 0.97, LMAT pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.97% |
5.2 History
On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
LMAT pays out 33.89% of its income as dividend. This is a sustainable payout ratio.
The dividend of LMAT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.89%
EPS Next 2Y11.97%
EPS Next 3Y12.28%
NASDAQ:LMAT (7/25/2025, 10:32:43 AM)
80.93
+0.16 (+0.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners94.92%
Inst Owner Change0.81%
Ins Owners8.54%
Ins Owner Change-3.07%
Market Cap1.83B
Analysts76.47
Price Target106.59 (31.71%)
Short Float %7.05%
Short Ratio8.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.97% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP33.89%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.01%
Min EPS beat(2)-5.52%
Max EPS beat(2)-2.5%
EPS beat(4)2
Avg EPS beat(4)2.64%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)5.59%
EPS beat(12)7
Avg EPS beat(12)-0.64%
EPS beat(16)8
Avg EPS beat(16)-1.01%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)1.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.34%
PT rev (1m)0%
PT rev (3m)-1.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.87 | ||
| Fwd PE | 33.27 | ||
| P/S | 8.08 | ||
| P/FCF | 44.46 | ||
| P/OCF | 38.01 | ||
| P/B | 5.26 | ||
| P/tB | 7.39 | ||
| EV/EBITDA | 22.48 |
EPS(TTM)1.98
EY2.45%
EPS(NY)2.43
Fwd EY3.01%
FCF(TTM)1.82
FCFY2.25%
OCF(TTM)2.13
OCFY2.63%
SpS10.02
BVpS15.39
TBVpS10.94
PEG (NY)3.09
PEG (5Y)2.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.12% | ||
| ROE | 12.99% | ||
| ROCE | 9.98% | ||
| ROIC | 7.67% | ||
| ROICexc | 17.81% | ||
| ROICexgc | 31.73% | ||
| OM | 23.43% | ||
| PM (TTM) | 19.96% | ||
| GM | 68.8% | ||
| FCFM | 18.17% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexcg growth 3Y-0.4%
ROICexcg growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 4.09 | ||
| Debt/EBITDA | 2.67 | ||
| Cap/Depr | 70.88% | ||
| Cap/Sales | 3.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.52% | ||
| Profit Quality | 91.04% | ||
| Current Ratio | 16.49 | ||
| Quick Ratio | 13.83 | ||
| Altman-Z | 7.18 |
F-Score5
WACC8.81%
ROIC/WACC0.87
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)31.13%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%9.09%
EPS Next Y13.23%
EPS Next 2Y11.97%
EPS Next 3Y12.28%
EPS Next 5Y8.65%
Revenue 1Y (TTM)13.19%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.95%
Revenue Next Year11.52%
Revenue Next 2Y10.16%
Revenue Next 3Y10.14%
Revenue Next 5Y9.07%
EBIT growth 1Y29.64%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year37.67%
EBIT Next 3Y21.1%
EBIT Next 5YN/A
FCF growth 1Y126.79%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y109.55%
OCF growth 3Y7.93%
OCF growth 5Y25.49%